Leading heart experts say the results were "somewhat surprising," and their discovery could warrant a conversation with your ...

ESTERO, FL / ACCESS Newswire / November 6, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), ...

LONDON (Reuters) - A new study backs up a suggestion that high dosages of aspirin may interfere with AstraZeneca's heart drug Brilinta, offering a possible explanation for disappointing results from a ...

Aspirin use in patients with PIK3CA-mutated colorectal cancer reduces recurrence risk by over 50%, found a study published in the Journal of Clinical Oncology. The findings could lead to immediate ...

Aspirin is a drug that's both cheap and available and it's used by millions of people, mainly to ease headache pain and counter the effects of heart disease. Now researchers have found that a daily ...

(Reuters) -Bristol Myers Squibb and Johnson & Johnson said on Friday they would stop a late-stage trial of their experimental ...

New research found that taking aspirin regularly can lower a person’s chance of developing colorectal cancer. Aspirin was beneficial in general, but it led to the biggest risk reduction among people ...

A Scandinavian clinical trial has revealed that low-dose aspirin can halve the risk of colon and rectal cancer recurrence in patients with specific genetic mutations. The research, involving over ...

The MarketWatch News Department was not involved in the creation of this content. Rise in prevalence of cardiovascular diseases (CVDS), expanding applications in pain management & fever reduction, and ...

Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a new post hoc analysis of aspirin use in REDUCE-IT® reinforcing that ...